Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 73, Issue 1, 2010, Pages 25-33

  Dal Negro, Roberto W ^a,b   Aquilani, R ^c   Bertacco, S ^a   Boschi, F ^d   Micheletto, C ^a   Tognellai, S ^a  

^a Ospedale Orlandi   (Italy)

^b Centro Nazionale Studi di Farmacoeconomia e Farmacoepidemiologia Respiratoria   (Italy)

^c IRCCS   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

COPD; Essential amino acids supplementation; Sarcopenia

Indexed keywords

ESSENTIAL AMINO ACID; LACTIC ACID;

AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENERGY METABOLISM; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LACTATE BLOOD LEVEL; MALE; MUSCLE ATROPHY; MUSCLE METABOLISM; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

EID: 77952680095     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2010.310     Document Type: Article

References (55)

1. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438
2. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7: 1793-1797
3. Vandenbergh E, Van de Woestijne KP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. Am Rev Respir Dis 1967; 95: 556-566
4. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc 1999; 58: 321-328 (Pubitemid 29398115)
5. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156 (Pubitemid 23149871)
6. Schols AM, Mostert R, Soeters PB, Wouters EF. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695-699
7. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980 (Pubitemid 26081648)
8. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152 (6 Pt 1): 2021-2031
9. Foley RJ, ZuWallack R. The impact of nutritional depletion in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001; 21: 288-295 (Pubitemid 32899711)
10. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59 (Pubitemid 41716377)
11. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157 (6 Pt 1): 1791-1797 (Pubitemid 28311260)
12. Creutzberg EC, Wouters EF, Mostert R, Weling-Scheepers CA, Schols AM. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003; 19: 120-127
13. De Boer WI. Cytokines and therapy in COPD: a promising combination? Chest 2002; 121 (5 Suppl): 209S-218S.
14. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 1997; 156: 1800-1806 (Pubitemid 28011785)
15. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152 (4 Pt 1): 1268-1274
16. Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998; 114: 19-28.
17. Yeh SS, DeGuzman B, Kramer T; M012 Study Group. Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest 2002; 122: 421-428 (Pubitemid 35002116)
18. Franssen FM, Broekhuizen R, Janssen PP, Wouters EF, Schols AM. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest 2004; 125: 2021-2028 (Pubitemid 38788165)
19. Palange P, Forte S, Onorati P, Paravati V, Manfredi F, Serra P, Carlone S. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 1998; 114: 12-18
20. Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002; 76: 113-119
21. Volpi E, Ferrando AA, Yeckel CW, Tipton KD, Wolfe RR. Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 1998; 101: 2000-2007 (Pubitemid 28226120)
22. Layman DK. Role of leucine in protein metabolism during exercise and recovery. Can J Appl Physiol 2002; 27: 646-663
23. Iritani N, Sugimoto T, Fukuda H, Komiya M, Ikeda H. Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 1997; 127: 1077-1083 (Pubitemid 27242104)
24. Jousse C, Bruhat A, Ferrara M, Fafournoux P. Physiological concentration of amino acids regulates insulin-like-growth-factor-binding protein 1 expression. Biochem J 1998; 334 (Pt 1): 147-153 (Pubitemid 28420983)
25. Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 134-137
26. Isoaho R, Puolijoki H, Huhti E, Laippala P, Kivelä SL. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr 1996; 8: 113-125 (Pubitemid 26248777)
27. Fernstrom ID, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 1987; 72: 897-901.
28. Pouw EM, Schols AM, van der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 453-457
29. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71: 1033-1047
30. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824
31. Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas D. Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 2002; 96: 594-598
32. Vary TC, O'Neill P, Cooney RN, Maish G 3rd, Shumate M. Chronic infusion of interleukin 1 induces hyperlactatemia and altered regulation of lactate metabolism in skeletal muscle. J Parenter Enteral Nutr 1999; 23: 213-217 (Pubitemid 29309751)
33. Xia Y, Warshaw JB, Haddad GG. Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult rats. Am J Physiol 1997; 273 (5 Pt 2): R1734-41.
34. Pastoris O, Dossena M, Foppa P, et al. Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism. Neurochem Res 1995; 20: 143-150
35. Terjung RL, Dudley GA, Meyer RA. Metabolic and circulatory limitations to muscular performance at the organ level. J Exp Biol 1985; 115: 307-318
36. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335 (25): 1897-1905
37. nd ed.: 1994.
38. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000; 85: 109-117
39. Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M. Lung function and cognitive ability in a longitudinal birth cohort study. Psychosom Med 2005; 67: 602-608 (Pubitemid 41033590)
40. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006; 20: 99-106.
41. Incalzi RA, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 1993; 148: 418-424
42. Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002; 12; 58: 758-764
43. Steiner MC, Barton RL, Singh SJ, Morgan MD. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2003; 58: 745-751 (Pubitemid 37094048)
44. Weisberg J, Wanger J, Olson J, et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 2002; 121: 1070-1078 (Pubitemid 34280424)
45. Kimball SR, Fabian JR, Pavitt GD, Hinnebusch AG, Jefferson LS. Regulation of guanine nucleotide exchange through phosphorylation of eukaryotic initiation factor eIF2alpha. Role of the alpha- and delta-subunits of eiF2b. J Biol Chem 1998; 273: 12841-12845
46. Wang X, Campbell LE, Miller CM, Proud CG. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J 1998; 334: 261-267 (Pubitemid 28420997)
47. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 46: 76s-80s. (Pubitemid 37351739)
48. Scognamiglio R, Negut C, Palisi M, Dioguardi FS, Coccato M, Iliceto S. Effects of oral amino acid supplements on cardiac function and remodeling in patients with type 2 diabetes with mild-to-moderate left ventricular dysfunction. Am J Cardiol 2008; 101: 111E-115E.
49. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161 (4 Pt 1): 1179-1184
50. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Sigel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic Neurochemistry. Philadelphia: Lippincott-Raven; 1998: 637-669
51. Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H, Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 1992; 72: 1978-1984
52. Ziegler MG, Nelesen R, Mills P, Ancoli-Israel S, Kennedy B, Dimsdale JE. Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep 1997; 20: 224-231 (Pubitemid 27242272)
53. Kim DK, Natarajan N, Prabhakar NR, Kumar GK. Facilitation of dopamine and acetylcholine release by intermittent hypoxia in PC12 cells: involvement of calcium and reactive oxygen species. J Appl Physiol 2004; 96: 1206-1215 (Pubitemid 38248703)
54. Baldi S, Aquilani R, Poggi P, Venegoni E. Fat-free mass change after nutritional rehabilitation in weight loosing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J COPD 2009 submitted.
55. Aquilani R, Opasich C, Gualco A, et al. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail 2008; 10: 1127-1135